ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 678033 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 678033; 2) Community: the network communities that were significantly associated with the response to NSC 678033; 3) Molecule: the relationships between components within communities and NSC 678033; 4) MDR: the compounds that were significantly associated with the NSC 678033.

NSC Compound Enrichment Correlation
NSC 667909 Null 0.000839001373926613 0.31931548
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.000839001373926613 0.52308375
NSC 758670 TANNIC ACID 0.000839001373926613 -0.21213011
NSC 317917 1-Propanone, 3-(dimethylamino)-2-[(dimethylamino)methyl]-1-(4-methoxyphenyl)-, dihydrochloride 0.000864859564133836 0.64368478
NSC 382001 2-Propen-1-one, 2-[(dimethylamino)methyl]-1-(2,5-dimethyl phenyl)-, hydrochloride 0.000864859564133836 0.75243971
NSC 624488 Streptomyces antibiotic SF-2446-A-1 0.000864859564133836 0.43515297
NSC 632791 Platinum, dichloro[(methylsulfinyl)phenyl-S](quinoline-N)-, (SP-4-1) 0.000864859564133836 0.78060219
NSC 641394 1H-Benzo[a]carbazole-1,4(11H)-dione, 11-phenyl- 0.000864859564133836 0.7243898
NSC 655105 Cycloshikonin 0.000864859564133836 0.69173311
NSC 68093 Null 0.000864859564133839 0.67313085
Total:156  Current:10    [First] [Prev] [Next] [Last]